[11] Francis A, Lopez-Canino A: Delirium with catatonic features: a new subtype?  Psychiatric Times 2009;26(7)

[12] Grover S, Ghosh A, Ghormode D: Do patients of delirium have catatonic features?  An exploratory study. Psychiatry Clin Neurosci 2014;68(8):644-51

[13] Mann SC, Caroff SN, Ungvari GS, Campbell EC: Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome.  Curr Psychiatry Rev 2013;9:111-119

[14] Philbrick KL, Rummans TA: Malignant catatonia.  J Neuropsychiatry Clin Neurosci 1994;6:1-13

[15] Fink M: Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 1996;39:1–4

[16] Fink M, Taylor MA (2003). The many faces of catatonia.  In: Catatonia: a clinician’s guide to diagnosis and treatment. (pp. 45-50). Cambridge, UK:Cambridge University Press

[17] Mann SC, Caroff SN, Bleier HR, Welz WK, Kling MA, Hayashida M: Lethal catatonia. Am J Psychiatry 1986;143:1374–1381

[18] Fink M, Taylor MA (2003). The many faces of catatonia.  In: Catatonia: a clinician’s guide to diagnosis and treatment. (pp. 50-58). Cambridge, UK:Cambridge University Press

[19] Jacobowski NL, Heckers S, Bobo WV:  Delirious mania: detection, diagnosis, and clinical management in the acute setting.  J Psychiatr Pract 2013;19(1):15-28

[20] Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT:  Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria.  J Neurotrauma 2014;31(17):1515-1520

[21] Diesing TS, Wijdicks EF: Arc de cercle and dysautonomia from anoxic injury.  Mov Disord 2006;21(6):868-869

[22] Blackman JA, Patrick PD, Buck ML, Rust Jr RS: Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol 2004;61:321-328

[23] Gelenberg AJ: The catatonic syndrome.  Lancet 1976;1(7973):1339-1341

[24] Vilke GM, Payne-James J, Karch SB: Excited delirium syndrome (ExDS): redefining an old diagnosis.  J Forensic Leg Med 2012;19(1):7-11

[25] Penders TM, Gestring RE, Vilensky DA: Excited delirium following use of synthetic cathinones (bath salts). Gen Hosp Psychiatry 2012;34(6):647-650

[26] Vilke GM, DeBard ML, Chan TC, Ho JD, Dawes DM, Hall C, Curtis MD, Costello MW, Mash DC, Coffman SR, McMullen MJ, Metzger JC, Roberts JR, Sztajnkrcer MD, Henderson SO, Adler J, Czarnecki F, Heck J, Bozeman WP: Excited Delirium Syndrome (ExDS): defining based on a review of the literature.  J Emerg Med 2012;43(5):897-905

[27] Cohen D, Nicolas JD, Flament MF, Perisse D, Dubos PF, Bonnot O, Speranza M, Graindorge C, Tordjman S, Mazet P: Clinical relevance of chronic catatonic schizophrenia in children and adolescents: evidence from a prospective naturalistic study. Schizophr Res 2005;76:301-308

[28] Takaoka K, Takata T: Catatonia in childhood and adolescence. Psychiatry Clin Neurosci 2003;57:129-137

[29] Cornic F, Consoli A, Tanguy ML, Bonnot O, Perisse D, Tordjman S, Laurent C, Cohen D: Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Schizophr Res 2009;113:233-240

[30] Ghaziuddin N, Dhossche D, Marcotte K: Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand 2012;125:33–38

[31] Consoli A, Raffin M, Laurent C, Bodeau N, Campion D, Amoura Z, Sedel F, An-Gourfinkel I, Bonnot O, Cohen D: Medical and developmental risk factors of catatonia in children and adolescents: a prospective case-control study. Schizophr Res 2012;137:151-158

[32] Lahutte B, Cornic F, Bonnot O, Consoli A, An-Garfunkel I, Amoura Z, Sedel F, Cohen D: Multidisciplinary approach of organic catatonia in children and adolescents may improve treatment decision making. Prog Neuro-Psychopharmacol Biol Psychiatry 2008;32:1393-1398

[33] Dhossche DM, Rout U: Are autistic and catatonic regression related?  A few working hypotheses involving gaba, Purkinje cell survival, neurogenesis, and ECT. Int Rev Neurobiol 2006;72:55-79

[34] Wing L, Shah A: Catatonia in autistic spectrum disorders. Br J Psychiatry 2000;176:357–362.

[35] Billstedt E, Gillberg IC, Gillberg C: Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord 2005;35(3):351-360

[36] Mazzone L, Postorino V, Valeri G, Vicari S: Catatonia in patients with autism: prevalence and management. CNS Drugs 2014;28:205-215

[37] Raffin M, Zugaj-Bensaou L, Bodeau N, Milhiet V, Laurent C, Cohen D, Consoli A: Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry 2014 Aug 27. [Epub ahead of print]

[38] Zarr ML, Nowak T:  Catatonia and burns. Burns 1990;16(2):133-134

[39] Carroll BT, Spetie L: Catatonia on the consultation-liaison service: a replication study. Int J Psychiatry Med 1994;24(4):329-337

[40]Cottencin O, Warembourg F, de Chouly de Lenclave MB, Lucas B, Vaiva G, Goudemand M, Thomas P:  Catatonia and consultation-liaison psychiatry study of 12 cases. Prog Neuro-Psychopharmacol Biol Psychiatry 2007;31:1170-1176

[41] Jaimes-Albornoz W, Serra-Mestres J. Prevalence and clinical correlations of catatonia in older adults referred to a liaison psychiatry service in a general hospital. Gen Hosp Psychiatry 2013;35(5):512-6

[42] Joshi P, Aftab Z, Denysenko L: Catatonia in the community hospital consultation-liaison service setting: incidence, characteristics, and the implementation of a new screening tool. Poster session presented at: 61st Annual Meeting of the Academy of Psychosomatic Medicine;2014 Nov 12-15; Fort Lauderdale, FL.

[43] Smith JH, Smith VD, Philbrick KL, Kumar N: Catatonic disorder due to a general medical or psychiatric condition. J Neuropsychiatry Clin Neurosci 2012;24:198-207

[44] Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR: Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098

[45] Schimmel M, Bien CG, Vincent A, Schenk W, Penzien J: Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child 2009;94:314-316

[46] Lee A, Glick DB, Dinwiddie SH: Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis. J ECT 2006;22(4():267-270

[47] DeSena AD, Greenberg BM, Graves D: Three phenotypes of anti-n-methyl-d-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis. Pediatr Neurol 2014;51(4):542-549

[48] Wilson JE, Shuster J, Fuchs C: Anti-NMDA receptor encephalitis in a 14-year-old female presenting as malignant catatonia: medical and psychiatric approach to treatment. Psychosomatics 2013;54:585-589

[49] Dalmau J, Rosenfeld MR: Paraneopalstic syndromes of the CNS. Lancet Neurol 2008;7(4):327-340

[50] Ramanathan S, Wong CH, Fung VSC: Long duration between presentation of probable anti-N-methyl-D-aspartate receptor encephalitis and either clinical relapse or positive serum autoantibodies. J Clin Neurosci 2013;20:1322-1323

[51] Tandon R, Walden M, Falcon S: Catatonia as a manifestation of paraneoplastic encephalopathy. J Clin Psychiatry 1988;49(3):121-122

[52] Grover S, Parakh P, Sharma A, Rao P, Modi M, Kumar A: Catatonia in systemic lupus erythematosus: a case report and review of literature. Lupus 2013;22:634-638

[53] Mon T, L’ecuyer S, Farber NB, White AJ, Baszis KW, Hearn JK, Spiegel TE, French AR, Kitcharoensakkul M: Lupus 2012;21(14):1575-1581

[54] Leon T, Aguirre A, Pesce C, Sanhueza P, Toro P: Electroconvulsive therapy for catatonia in juvenile neuropsychiatric lupus. Lupus 2014 Apr 30 [Epub ahead of print]

[55] Gomez EA, Comstock BS, Rosario A:  Organic versus functional etiology in catatonia: a case report. J Clin Psychiatry 1982;43:200-201

[56] Primavera A, Fonti A, Novello P, Roccatagliata G, Cocito L:  Epileptic seizures in patients with acute catatonic syndrome. J Neurol Neurosurg Psychiatry 1994;57:1419-1422

[57] Lim J, Yagnik P, Schraeder P, Wheeler S:  Ictal catatonia as a manifestation of non-convulsive status epilepticus. J Neurol Neurosurg Psychiatry 1986;49:833-836

[58] Kanemoto K, Miyamoto T, Abe R: Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal. Seizure 1999;8:364-366

[59] Lopez-Alberola R, Georgiou M, Sfakianakis GN, Singer C, Papapetropoulos S: Contemporary encephalitis lethargica: phenotype, laboratory findings and treatment outcomes. J Neurol 2009;256:396-404

[60] Ono Y, Manabe Y, Hamakawa Y, Omori N, Abe K: Steroid-responsive encephalitis lethargica syndrome with malignant catatonia. DOI: 10.2169/internalmedicine.46.6179

[61] Hassan H, Thomas B, Iyer RS: Insights from a rare clinical presentation of herpes simplex encephalitis: adding to the catatonic dilemma?  Neurologist 2011;17(2):114-116

[62] Aggarwal A, Jain M, Jiloha R: Catatonia as the initial presenting feature of subacute sclerosing panencephalitis. J Neuropsychiatry Clin Neurosci. 2011;23(1):E29-31

[63] Lauterbach EC, Norris BK, Carter WG, Shillcutt SD: Catatonia and CPK elevation in neurosyphilis: role of plural pharmacodynamics mechanisms. Psychopharmacol Bull 2009;42(4):53-63

[64] Pfister HW, Preac-Mursic V, Wilske B, Rieder G, Förderreuther S, Schmidt S, Kapfhammer HP: Catatonic syndrome in acute severe encephalitis due to borrelia burgdorferi infection. Neurology 1993;43(2):433-435

[65] Talukdar P, Dutta A, Rana S, Talukdar A: Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience. BMJ Case Rep 2013 Jun 27. Doi: 10.1136/bcr-2013-010220

[66] Alfson ED, Awosika OO, Singhal T, Fricchione GL: Lysis of catatonic withdrawal by propofol in a bone-marrow transplant recipient with adenovirus limbic encephalitis. Psychosomatics 2013;54(2):192-195

[67] Shah R, Chakrabarti S: Neuropsychiatric manifestations and treatment of disseminated neurocysticercosis: a compilation of three cases. Adian J Psychiatr 2013;6(4):344-346

[68] Prakash O, Bagepally BS: Catatonia and mania in patient with AIDS: treatment with lorazepam and risperidone. Gen Hosp Psychiatry 2012;34(3):e5-6

[69] Huffman JC, Fricchione GL: Catatonia and psychosis in a patient with AIDS: treatment with lorazepam and aripiprazole. J Clin Psychopharmacol 2005;25(5):508-510

[70] Kumar P, Jain MK: Progressive multifocal leucoencephalopathy in AIDS camouflaged with catatonia: a wolf in sheep’s clothing. Indian J Psychaitry 2006;48(1):69-71

[71] Foster R, Olajide D, Everall P: Antiretroviral therapy-induced psychosis: case report and brief review of the literature. HIV Med 2003;4(2):139-144

[72] Mattson MP, Haughey NJ, Nath A:  Cell death in HIV dementia. Cell Death Differ 2005;12(Supp 1):893-904

[73] Heyes MP, Ellis RJ, Ryan L, Childers ME, Grant I, Wolfson T, Archibald S, Jernigan TL:  Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001;124(Pt 5):1033-1042

[74] Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, ter Meulen V, Koutsilieri E:  Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology: 2008;33(9):2228-2236

[75] Sheline YI, Miller MB:  Catatonia relieved by oral diazepam in a patient with a pituitary microadenoma. Psychosoamtics 1986;27(12):860-862

[76] Arora M, Praharaj SK:  Butterfly glioma of corpus callosum presenting as catatonia. World J Biol Psychiatry 2007;8(1):54-55

[77] Sternbach H, Yager J: Catatonia in the presence of mid-brain and brainstem abnormalities. J Clin Psychiatry 1981;42(9):352-353

[78] Neuman E, Rancurel G, Lecrubier Y, Fohanno D, Boller F: Schizophreniform catatonia on 6 cases secondary to hydrocephalus with subthalamic mesencephalic tumor associated with hypodopaminergia. Neuropsychobiology 1996;34(2):76-81

[79] Ries R, Bokan J: Electroconvulsive therapy following pituitary surgery. J Nerv Ment Dis 1979;167(12):767-768

[80] Massengale J, Tafti BA, Large L, Skirboll S:  Reversal of preoperative catatonic state by surgical resection of an adult-onset craniopharyngioma: case report and review of the literature. Cogn Behav Neurol 2009;22(1):67-71

[81] Boudin G, Nick J, Bureau G, Blanchet G, Hillemand B: [State of stupor with catatonia revealing multiple sclerosis]. Rev Neurol (Paris) 1953;88(4):273-275

[82] Mendez MF: Multiple sclerosis presenting as catatonia. Int J Psychiatry Med 1999;29(4):435-41

[83] Hung YY, Huang TL: Lorazepam and diazepam for relieving catatonic features in multiple sclerosis. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(7):1537-1538

[84] Blanc F, Berna F, Fleury M, Lita L, Ruppert E, Ferriby D, Vermersch P, Vidailhet P, de Seze J: [Inaugural psychotic events in multiple sclerosis?]. Rev Neurol (Paris) 2010;166(1):39-48

[85] Shoja Shafti S, Nicknam Z, Fallah P, Zamani L: Early psychiatric manifestation in a patient with primary progressive multiple sclerosis. Arch Iran Med 2009;12(6):595-598

[86] Pontikes TK, Dinwiddie SH: Electroconvulsive therapy in a patient with multiple sclerosis and recurrent catatonia. J ECT 2010;26(4):270-271

[87] Desai NG, Patil NM, Gangadhar BN, Pradhan N, Channabasavanna SM: Catatonia associated with uraemic encephalopathy. Indian J Psychiatry 1984;26(1):95-96

[88] Quinn DK: “Burn catatonia”: a case report and literature review. J Burn Care Res 2014;35(2):e135-142

[89] Spiegel DR, Varnell C Jr: A case of catatonia due to posterior reversible encephalopathy syndrome treated successfully with antihypertensives and adjunctive olanzapine. Gen Hosp Psychiatry 2011;33(3):302.e3-5

[90] Kitabayashi Y, Hamamoto Y, Hirosawa R, Narumoto J, Fukui K: Postpartum catatonia associated with atypical posterior reversible encephalopathy syndrome. J Neuropsychiatry Clin Neurosci 2007;19(1):91-92

[91] Francis A, Lopez-Canino A:  Delirium with catatonic features: a new subtype?  Psychiatric Times 2007;26(7):  accessed online: http://www.psychiatrictimes.com/display/article/10168/1427195

[92] Dern RJ, Glynn MF, Brewer GJ: Studies on the correlation of the genetically determined trait G-6-P-D deficiency with behavioral manifestations of schizophrenia. J Lab Clin Med 1963;62:319

[93] Fieve RR, Brauninger G, Fleiss J, Cohen G: Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior. J Psychiatr Res 1965;3:255-262

[94] Bocchetta A: Psychotic mania in glucose-6-phospahte-dehydrogenase-deficient subjects. Ann Gen Hosp Psychaitry 2003;2(1):1-6

[95] Raj V, Chism K, Minckler MR, Denysenko L: Catatonia and glucose-6-phosphate dehydrogenase deficiency: a report of two cases and a review. Psychosomatics 2014;55(1):92-97

[96] Catalano G, Catalano MC, Rosenberg EI, Embi PJ, Embi CS:  Catatonia. Another neuropsychiatric presentation of vitamin B12 deficiency?  Psychosomatics 1998;39(5):456-460

[97] Berry N, Sagar R, Tripathi BM:  Catatonia and other psychiatric symptoms with vitamin B12 deficiency. Acta Psychiatr Scand 2003;108(2):156-159

[98] Dogan M, Ozdemir O, Sal EA, Dogan SZ, Ozdemir P, Cesur Y, Caksen H:  Psychotic disorder and extrapyramidal symptoms associated with vitamin B12 and folate deficiency. J Trop Pediatr 2009;55(3):205-207

[99] Lewis AL, Pelic C, Kahn DA:  Malignant catatonia in a patient with bipolar disorder, B12 deficiency, and neuroleptic malignant syndrome: one cause or three?  J Psychiatr Pract 2009;15(5):415-422

[100] Seaman S: Seeing catatonia. J Neuropsychiatry Clin Neurosci 2005;17:558-559

[101] Lee JW, Schwartz DL: Catatonia associated with hyponatremia. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:63-64

[102] Nizamie SH, Khanna R, Sharma LN: Catatonia and hyponatremia: a case report. Indian J Psychiatry 1991;33(2):118-122

[103] Grover S, Somaiya M, Ghormode D: Venlafaxine-associated hyponatremia presenting with catatonia. J Neuropsychiatry Clin Neurosci 2013;25(2):e11-12

[104] Yeh YW, Kuo SC, Chen CY, Shiah IS, Chen YC, Huang SY. Mimicking catatonic symptoms: a head injury induced acute hyponatremia complicated by rhabdomyolysis in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(4):731-732

[105] Grover S, Kattharaghatta Girigowda V, Aggarwal M, Malhotra N: Catatonia associated with hyponatremia treated with electroconvulsive therapy. J ECT 2012;28(3):e33-34

[106] Koussa S, Nasnas R: Catatonia and parkinsonism due to extrapontine myelinolysis following rapid correction of hyponatremia: a case report. J Neurol 2003;250:103-105

[107] Koenig M, Camdessanche JP, Duband S, Charmion S, Antoine JC, Cathébras P: [Extrapontine myelinolysis of favorable outcome in a patient with autoimmune polyglandular syndrome]. Rev Med Interne 2005;26(1):65-68

[108] Spiegel DR, Klaiber N: A case of catatonia status-post left middle cerebral artery cerebrovascular accident, treated successfully with olanzapine. Clin Neuropharmacol 2013;36(4):135-137

[109] Utumi Y, Iseki E, Arai H: Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy. Psychogeriatrics 2013;13(4):254-259

[110] Fekete R: Renal failure in dementia with lewy bodies presenting as catatonia. Case Rep Neurol 2013;5(1):10-13

[111] Ueda S, Koyama K, Kocha H, Okubo Y: [Dementia with Lewy bodies (DLB) accompanied by symptoms of late catatonia: what to consider and how to treat]. Seishin Shinkeigaku Zasshi 2013;113(2):144-156

[112] Maeda K, Ogawa N: Amitriptyline and lorazepam improved catatonia and occipital hypoperfusion in a patient with DLB. Intern Med 2011;50(4):363-6

[113] Xiong GL, Palomino A, Kahn DR, Bourgeois JA:  Antipsychotic induced catatonia: a case of probable dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 2009;21(4):472-473

[114] Morita S, Miwa H, Kondo T:  [A patient with probable dementia with Lewy bodies, who showed catatonia induced by donepezil: a case report]. No To Shinkei 2004;56(10):881-884

[115] Sobow T: Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series. Neurol Neurochir Pol 2007;41(3):276-279

[116] Minett TS, Thomas A, Wilkinson LM, Daniel SL, Sanders J, Richardson J, Littlewood E, Myint P, Newby J, McKeith IG: What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. Int J Getriatr Psychiatry 2003;18(11):988-993

[117] Singh D, Williams O:  Catatonia, major depression, and takotsubo cardiomyopathy in an elderly patient. Australas Psychiatry 2013;21:181-182

[118] Denysenko L, Shmuts R, Trenton A, Halpern EJ, Becker M: Takotsubo cardiomyopathy and catatonia: an acute stress connection? Poster session presented at: 59th Annual Meeting of the Academy of Psychosomatic Medicine; 2012; Nov 14-18; Atlanta, GA

[119] Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC: Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:529-548

[120] Northoff G, Demisch L, Wenke J, Pflug B:  Plasma homovanillic acid concentrations in catatonia. Biol Psychiatry 1996;39:436-443

[121] Nayak RB, Shetageri VN, Bhogale GS, Patil NM, Chate SS, Chattopadhyay S: Catatonia: a rare presenting symptom of Wilson's disease. J Neuropsychiatry Clin Neurosci 2012;24(3):E34-35

[122] Davis EJ, Borde M: Wilson's disease and catatonia. Br J Psychiatry 1993;162:256-259

[123] Akil M, Schwartz JA, Dutchak D, Yuzbasiyan-Gurkan V, Brewer GJ: Thepsychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci 1991;3(4):377-382

[124] Walshe JM, Yealland M: Wilson’s disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 1992;55:692–696

[125] Zimbrean PC, Schilsky ML: Psychiatric aspects of Wilson disease: a review. Gen Hosp Psychiatry 2014;36(1):53-62

[126] Carroll BT, Goforth HW:  Serum iron in catatonia. Biol Psychiatry 1995;38:775-777

[127] Rosebush PI, Mazurek MF:  Serum iron and neuroleptic malignant syndrome. Lancet 1991;338:149-151

[128] Lee JWY:  Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 1998;44:499-507

[129] Peralta V, Cuesta MJ, Mata I, Serrano JF, Perez-Nievas F, Natividad MC:  Serum iron in catatonic and noncatatonic psychotic patients. Biol Psychiatry 1999;45:788-790

[130] Muñoz P, Humeres A, Elgueta C, Kirkwood A, Hidalgo C, Núñez MT:  Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J Biol Chem 2011;286(15):13382-13392

[131] Kusztal M, Piotrowski P, Mazanowska O, Misiak B, Kantorska-Janiec M, Boratyńska M, Klinger M, Kiejna A:  Catatonic episode after kidney transplantation. Gen Hosp Psychiatry 2014 Jan 13. Doi: 10.1016/j.genhosppsych.2014.01.001

[132] Chopra A, Das P, Rai A, Kuppuswamy PS, Li X, Huston J, Philbrick K, Sola C: Catatonia as a manifestation of tacrolimus-induced neurotoxicity in organ transplant patients: a case series. Gen Hosp Psychiatry 2012;34(2):209.e9-11

[133] O'Donnell MM, Williams JP, Weinrieb R, Denysenko L: Catatonic mutism after liver transplant rapidly reversed with lorazepam. Gen Hosp Psychiatry 2007;29(3):280-281

[134] Toledo Perdomo K1, Navarro Cabello MD, Pérez Sáez MJ, Ramos Pérez MJ, Agüera Morales ML, Aljama García P: Reversible acute encephalopathy with mutism, induced by calcineurin inhibitors after renal transplantation. J Nephrol 2012;25(5):839-842

[135] Najera JE, Alousi A, De Lima M, Ciurea SO: Akinetic mutism-a serious complication to tacrolimus-based GVHD prophylaxis. Bone Marrow Transplant 2013;48(1):157-158

[136] Vearrier D, Simpson SE, Greenberg MI:  Mutism and persistent dysarthria due to tacrolimus-based immunosuppression following allogeneic liver transplantation. Am J Ther 2011;18(6):e274-276

[137] Chen SR, Hu YM, Chen H, Pan HL:  Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords. J Physiol 2014;592(Pt 1):215-227

[138] Bechstein WO:  Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000;13:313-326

[139] Ahn KJ, Lee JW, Hahn ST, Yang DW, Kim PS, Kim HJ, Kim CC:  Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 2003;76:916-919

[140] Bernstein L, Levin R: Catatonia responsive to intravenous lorazepam in a patient with cyclosporine neurotoxicity and hypomagnesemia. Psychosomatics 1994;34(1):102-103

[141] Bronster DJ, Boccagni P, O'Rourke M, Emre S, Schwartz M, Miller C:  Loss of speech after orthotopic liver transplantation. Transpl Int 1995;8(3):234-237

[142] Valldeoriola F, Graus F, Rimola A, Andreu H, Santamaria J, Catafau A, Visa J, Tolosa E, Rodés J: Cyclosporine-associated mutism in liver transplant patients. Neurology 1996;46(1):252-254

[143] Shuto H, Kataoka Y, Fujisaki K, Nakao T, Sueyasu M, Miura I, Watanabe Y, Fujiwara M, Oishi RL  Inhibition of GABA system involved in cyclosporine-induced convulsions. Life Sci 1999;65(9):879-887

[144] Masi G, Mucci M, Floriani C: Acute catatonia after a single dose of ecstasy. J Am Acad Child Adolesc Psychiatry 2002;41(8):892

[145] Lee JW: Catatonic stupor after “ecstasy”. BMJ 1994;308(6930):717-718

[146] Maxwell DL, Polkey MI, Henry JA: Hyponatremia and catatonic stupor after taking “ecstasy”. BMJ 1993;307(6916):1399

[147] Bhangle SD, Kramer N, Rosenstein ED: Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int 2013;33(8):1923-1932

[148] Grigg JR: Prednisone mood disorder with associated catatonia. J Geriatr Psychiatry Neurol 1989;2(1):21-44

[149] Sullivan BJ, Dickerman JD: Steroid associated catatonia: report of a case. Pediatrics 1979;63(4):677-679

[150] Dada MU, Oluwole L, Obadeji A, Ajayi OA: Dexamethasone induced psychosis presenting with catatonic features. Aft J Psychiatry (Johannesbg) 2011;14(4)316-318

[151] Akhtar S, Ahmad H: Ciprofloxacin-induced catatonia. J Clin Psychiatry 1993;54(3):115-116

[152] Youssef NA, Benazzi F, Desan PH: Prog Neuropsychopharmacol Biol Psychiatry 2009;33(4):741-742

[153] Grassi L, Biancosino B, Pavanati M, Agostini M, Manfredini R: Depression or hypoactive delirium?  A report of ciprofloxacin-induced mental disorder in a patient with chronic obstructive pulmonary disease. Psychother Psychosom 2001;70:58-59

[154] Al-Ghamdi SMG: Reversible encephalopathy and delirium in patients with chronic renal failure who had received ciprofloxacin. Saudi J Kidney Dis Transplant 2002;13(2):163-170

[155] Denysenko L, Nicolson SE: Cefoxitin and ciprofloxacin neurotoxicity and catatonia in a patient on hemodialysis. Psychosomatics 2011;52(4):379-383

[156] Plana MT, Blanch J, Romero S, Serra M, Gasto C: Toxic catatonia secondary to azithromycin. J Clin Psychiatry 2006;67(3):492-493

[157] Liddon S, Satran R: Disulfiram (Antabuse) psychosis. Am J Psychiatry 1967;123:1284-1289

[158] Knee S, Razani J: Acute organic brain syndrome: a complication of disulfiram therapy. Am J Psychiatry 1974;131:1281-1282

[159] Reisberg B: Catatonia associated with disulfiram therapy. J Nerv Ment Dis 1978;166:607-609

[160] Weddington W, Marks R, Verhese P:  Disulfiram encephalopathy as a cause of the catatonia. Am J Psychiatry 1980;137:1217-1219

[161] Fisher M: ‘Catatonia’ due to disulfiram toxicity. Arch Neurol 1989;46:798-804

[162] Wilson WH: Catatonia and encephalopathy following a disulfiram overdose. Wis Med J 1984;83(9):15-16

[163] Hajela R, Cunningham GM, Kapur BM, Peachey JE, Devenyi P:  Catatonic reaction to omeprazole and disulfiram in a patient with alcohol dependence. CMAJ 1990;143(11):1207-1208

[164] Schmuecker JD, Meloy JR, Williams DJ:  Disulfiram toxicity and catatonia in a forensic outpatient. Am J Psychiatry 1992;149(9):1275-1276

[165] Mirsal H, Yalug I, Tan D, Stern TA, Kalyoncu A, Pektas O, Erdogan G, Beyazyürek M:  Delirium-associated disulfiram and ethanol interactions. Prim Care Companion J Clin Psychiatry 2005;7(5):235-237

[166] Saddichha S, Phutane V, Thirthalli J:  De novo dose-dependent catatonia due to disulfiram therapy: a report and review. J Clin Pharmacol 2011;51(2):285-286

[167] Geoffroy PA, Rolland B, Cottencin O: Catatonia and alcohol withdrawal: a complex and underestimated syndrome. Alcohol Alcohol 2012;47(3):288-290

[168] Muralidharan K, Rajkumar RP, Ananthapadmanabha Rao S, Benegal V:  Catatonia as a presenting feature of alcohol withdrawal: a case report. Prim Care Companion J Clin Psychiatry 2007;9(6):465

[169] Cottencin O, Danel T, Goudemand M, Thomas P, Consoli SM:  Catatonia recognition and treatment. Med Sci Monit 2009;15(8):CS 129-131

[170] Narayanaswamy JC, Viswanath B, Jose SP, Chakraborty V, Subodh BN, Benegal V:  Catatonia in alcohol withdrawal: a case report. Psychopathology 2011;44(2):136

[171] Hauser P, Devinsky O, De Bellis M, Theodore WH, Post RM:  Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders. Arch neurol 1989;46(6):696-699

[172] Rosebush PI, Mazurek MF:  Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol 1996;16(4):315-319

[173] Glover SG, Escalona R, Bishop J, Saldivia A:  Catatonia associated with lorazepam withdrawal. Psychosomatics 1997;38(2):148-150

[174] Kanemoto K, Miyamoto T, Abe R: Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal. Seizure 1999;8(6):364-366

[175] Deuschle M, Lederbogen F: Benzodiazepine withdrawal-induced catatonia. Pharmacopsychaitry 2001;34(1):41-42

[176] Brown M, Freeman S:  Clonazepam withdrawal-induced catatonia. Psychosomatics 2009;50(3):289-292

[177] Parameswaran R, Moore K, Hannan T, Austin M:  Catatonia associated with temazepam withdrawal. Aust N Z J Psychiatry 2011;45(11):1006-1007

[178] Amos JJ: Lorazepam withdrawal-induced catatonia. Ann Clin Psychiatry 2012;24(2):170-171

[179] Sivakumar T, Yadav A, Sood M, Khandelwal SK:  Lorazepam withdrawal catatonia: a case report. Asian J Psychiatr 2013;6(6):620-621

[180] Carroll BT: Catatonia due to mixed sedative withdrawal. J Neuropsychiatry Clin Neurosci 1997;9(2):303-304

[181] Campbell R, Schaffer CB, Tupin J: Catatonia associated with glutethimide withdrawal. J Clin Psychiatry 1983;44:32-33

[182] Rosebush PI, MacQueen GM, Mazurek MF:  Catatonia following gabapentin withdrawal. J Clin Psychopharmacol 1999;19(2):188-189

[183] Hsieh MH, Chen TC, Chiu NY, Chang CC:  Zolpidem-related withdrawal catatonia: a case report. Psychosomatics 2011;52(5):475-477

[184] Paulker SL, Brown R: Baclofen-induced catatonia. J Clin Psychopharmacol 1986;6(6):387-388

[185] Carroll BT, Thomas C, Tugrul KC, Coconcea C, Goforth HW:  GABAA versus GABAB in Catatonia. J Neuropsychiatry Clin Neurosci 2007;19:484

[186] Cremona-Barbaro A:  Neuroleptic-induced catatonic symptoms. Br J Psychiatry 1983;142:98-99

[187] Johnson GC, Manning DE:  Neuroleptic-induced catatonia: case report. J Clin Psychiatry 1983;44(8):310-312

[188] Fricchione GL, Cassem NH, Hooberman D, Hobson D:  Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983;3(6):338-342

[189] Gingrich JA, Rudnick-Levin F, Almeida C, Innes L, Schneier H:  Cocaine and catatonia. Am J Psychiatry 1998;155(11):1629

[190] Anbarasan D, Campion P, Howard J:  Drug-induced leukoencephalopathy presenting as catatonia. Gen Hosp Psychiatry 2011;33(1):85.e1-3

[191] McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA:  Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 1981;10(6):290-297

[192] Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI:  Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Euro J Clin Pharmacol 2012;68:853-856

[193] Fricchione GL, Cassem NH, Hooberman D, Hobson D: Intravenous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983;3:338-342

[194] McEvoy JP, Lohr JB: Diazepam for catatonia. Am J Psychaitry 1984;141:284-285

[195] Salam SA, Pillai AK, Beresford TP: Lorazepam for psychogenic catatonia. Am J Psychiatry 1987;144:1082-1083

[196] Greenfeld D, Conrad C, Kincare P, Bowers MB Jr: Treatment of catatonia with low-dose lorazepam. Am J Psychiatry 1987;144:1224-1225

[197] Salam SA, Kilzieh N: Lorazepam treatment of psychogenic catatonia: an update. J Clin Psychiatry 1988;49 Suppl:16-21

[198] Harris D, Menza MA: Benzodiazepines and catatonia: a case report. Can J Psychiatry 1989;34:725-727

[199] Yassa R, Iskandar H, Lalinec M et al: Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial. J Clin Pharmacol 1990;10:66-68

[200] Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF: Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990;51:357-362

[201] Ungvari GS, Leung CM, Wong MK et al: Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 1994;89:285-288

[202] Bush G, Fink M, Petrides G et al: Catatonia II: treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996;93:137-143

[203] Payee H, Chandrasekaran R, Raju GV: Catatonic syndrome: treatment response to lorazepam. Indian J Psychiatry 1999;41:49-53

[204] Hawkins JM, Archer KJ, Strakowski SM, Keck PE: Somatic treatment of catatonia. Int J Psychiatry Med 1995;25:345-369

[205] McCall WV, Shelp FE, McDonald WM: Controlled investigation of the amobarbital interview for catatonic mutism. Am J Psychiatry 1992;149:202-206. (Published erratum appears in Am J Psychiatry 1992;149:720.)

[206] Rosebush PI, Mazurek MF: Catatonia and its treatment. Schizophr Bull 2010;36:239-242

[207] Lee JW:  Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome. J Clin Psychopharmacol 2010;30:3-10

[208] Ungvari GS, Chiu HFK, Chow LY, Lau BST, Tang WK: Lorazepam for chronic catatonia: a randomized, double blind, placebo-controlled cross-over study. Psychopharmacology (Berl) 1999;142:393-398

[209] Zhang L, Shirayama Y, Iyo M, Hashimoto K:  Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology 2007;32(9):2004-2010

[210] Gideons ES, Kavalali ET, Monteggia LM:  Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc Natl Acad Sci U S A  2014 May 27. pii: 201323920. [Epub ahead of print]

[211] de Bartolomeis A, Sarappa C, Buonaguro EF, Marmo F, Eramo A, Tomasetti C, Iasevoli F: Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.  Prog Neuropsychopharmacol Biol Psychiatry 2013;46:1-12

[212] Seeman P, Caruso C, Lasaga M: Memantine agonist action at dopamine D2High receptors.  Synapse 2008;62(2):149-153

[213] Rammes G, Rupprecht R, Ferrari U, Zieglgänsberger W, Parsons CG:  The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner.  Neurosci Lett 2001;306:81-84

[214] Obregon DF, Velasco RM, Wuerz TP, Catalano MC, Catalano G, Kahn D:  Memantine and catatonia: a case report and literature review. J Psychiatr Pract 2011;17(4):292-299

[215] Thomas C, Carroll BT, Maley RT, Jayanti K, Koduri A:  Memantine and catatonic schizophrenia. Am J Psychiatry 2005;162(3):626

[216] Carpenter SS, Hatchett AD, Fuller MA:  Catatonic schizophrenia and the use of memantine. Ann Pharmacother 2006;40(2):344-346

[217] Munoz C, Yulan N, Achaval V, Appiani F, Carroll BT:  Memantine in major depression with catatonic features. J Neuropsychiatry Clin Neurosci 2008;20(1):119-120

[218] Utumi Y, Iseki E, Arai H:  Three patients with mood disorders showing catatonia and frontotemporal lobes atrophy. Psychogeriatrics 2013;13(4):254-259

[219] Northoff G, Eckert J, Fritze J:  Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 1997;62(4):404-406.

[220] Northoff G, Lins H, Böker H, Danos P, Bogerts B:  Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia. J Clin Psychopharmacol 1999;19(5):484-486

[221] Goforth H:  Amantadine in catatonia due to major depressive disorder in a medically ill patient. J Neuropsychiatry Clin Neurosci 2007;19(4):480-481

[222] de Lucena DF, Pinto JP, Hallak JE, Crippa JA, Gama CS:  Short-term treatment of catatonia with amantadine in schizophrenia and schizoaffective disorder. J Clin Psychopharmacol 2012;32(4):569-572

[223] Goetz M, Kitzlerova E, Hrdlicka M, Dhossche D:  Combined use of electroconvulsive therapy and amantadine in adolescent catatonia precipitated by cyber-bullying. J Child Adolesc Psychopharmacol 2013;23(3):228-231

[224] Ene-Stroescu V, Nguyen T, Waiblinger BE:  .Excellent response to amantadine in a patient with bipolar disorder and catatonia. J Neuropsychiatry Clin Neurosci 2014;26(1):E43

[225] Northoff G, Lins H, Böker H, Danos P, Bogerts B: Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia.  J Clin Psychopharmacol 1999;19:484-486

[226] Carroll BT, Goforth HW, Thomas C, Ahuja N, McDaniel WW, Kraus MF, Spiegel DR, Franco KN, Pozuelo L, Muñoz C:  Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 2007;19(4):406-412

[227] Yarns BD, Quinn DK: Telephone effect in akinetic mutism from traumatic brain injury. Psychosomatics 2013;54(6):609-610

[228] Caplan JP: Use of dextromethorphan/quinidine a glutamate modulator in catatonia. Poster session presented at: 61st Annual Meeting of the Academy of Psychosomatic Medicine;2014 Nov 12-15; Fort Lauderdale, FL.

[229] Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J:  Possible antipsychotic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(1):304-307

[230] Ahuja N, Carroll BT:  Possible anti-catatonic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(4):968-969

[231] Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I, Kron S:  A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry 2010;71(2):138-149

[232] Yacoub A, Francis A. Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Neuropsychiatr Dis Treat 2006;2(2):235-240

[233] Cassidy EM, O'Brien M, Osman MF, Finucane J, O'Keane V:  Lethal catatonia responding to high-dose olanzapine therapy. J Psychopharmacol 2001;15(4):302-304

[234] Nicolato R, Romano-Silva MA, Correa H, dos Santos RR, Teixeira AL:  Stuporous catatonia in an elderly bipolar patient: response to olanzapine. Aust N Z J Psychiatry 2006;40(5):498

[235] Tan QR, Wang W, Wang HH, Zhang RG, Guo L, Zhang YH. Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clin Neuropharmacol 2006;29(3):154-156

[236] Babington PW, Spiegel DR:  Treatment of catatonia with olanzapine and amantadine. Psychosomatics. 2007;48(6):534-536

[237] Guzman CS, Myung VH, Wang YP:  Treatment of periodic catatonia with atypical antipsychotic, olanzapine.

[238] Chang CH, Hsiao YL, Hsu CY, Chen ST:  Treatment of catatonia with olanzapine: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(8):1559-1560

[239] Suzuki H, Fukushima T, Makino K, Kuwabara T:  [Patient with encephalitis presenting with olanzapine-responsive malignant catatonia]. Rinsho Shinkeigaku 2010;50(5):329-331. Japanese.

[240] Ceylan MF, Kul M, Kultur SE, Kilincaslan A. Major depression with catatonic features in a child remitted with olanzapine. J Child Adolesc Psychopharmacol 2010;20(3):225-227

[241] Jauhar S, Blackett A, Srireddy P, McKenna PJ:  Pernicious anaemia presenting as catatonia without signs of anaemia or macrocytosis. Br J Psychiatry 2010;197(3):244-245

[242] Ueda S, Takeuchi J, Okubo Y:  Successful use of olanzapine for catatonia following delirium. Psychiatry Clin Neurosci 2012;66(5):465

[243] Kusztal M, Piotrowski P, Mazanowska O, Misiak B, Kantorska-Janiec M, Boratyńska M, Klinger M, Kiejna A:  Catatonic episode after kidney transplantation. Gen Hosp Psychiatry 2014;36(3):360.e3-5

[244] Girish K, Gill NS:  Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry 2003;45(1):21-25

[245] Petrides G, Malur C, Fink M. (2004). Convulsive Therapy. In: SN Caroff, SC Mann, A Francis, & GL Fricchione (Eds.), Catatonia: from psychopathology to neurobiology (pp. 153-157). Washington, DC: American Psychiatric Publishing

[246] Petrides G, Divadeenam KM, Bush G, Francis A:  Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry 1997;42(5):375-81

[247] Cristancho P, Jewkes D, Mon T et al: Successful use of right unilateral ECT for catatonia: a case series. J ECT 2013;30:69-72

[248] Kugler JL, Hauptman AJ, Collier SJ, Walton AE, Murthy S, Funderburg LG, Garcia KS: Treatment of Catatonia With Ultrabrief Right Unilateral Electroconvulsive Therapy: A Case Series. J ECT 2014 Sep 19 [Epub ahead of print]

[249] Nolen WA, Zwaan WA: Treatment of lethal catatonia with electroconvulsive therapy and dantrolene sodium: a case report.  Acta Psychiatr Scand 1990;82(1):90-92

[250] Van de Kelft E, De Hert M, Heytens L, Demey HE, Gheuens J: Management of lethal catatonia with dantrolene sodium.  Crit Care Med 1991;19(11):1449-1451

[251] Pennati A, Sacchetti E, Calzeroni A:  Dantrolene in lethal catatonia. Am J Psychiatry 1991;148(2):268

[252] Ferro FM, Janiri L, De Bonis C, Del Carmine R, Tempesta E: Clinical outcome and psychoendocrinological findings in a case of lethal catatonia.  Biol Psychiatry 1991;30(2):197-200

[253] Singerman B, Raheja R:  Malignant catatonia--a continuing reality.  Ann Clin Psychiatry 1994;6(4):259-266

[254] Tang CP, Leung CM, Ungvari GS, Leung WK: The syndrome of lethal catatonia. Singapore Med J 1995;36(4):400-402

[255] Bush G, Fink M, Petrides G et al: Catatonia I: rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-136

Catatonia in Medically Ill Patients

Main  | EBM Summary  |  References  |  Appendixes: A B C D